Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or waldenström macroglobulinemia

Journal of the National Cancer Institute

Volumn 102, Issue 8, 2010, Pages 557-567

  Kristinsson, Sigurdur Y ^a   Koshiol, Jill ^b   Björkholm, Magnus ^a   Goldin, Lynn R ^b   McMaster, Mary L ^b   Turesson, Ingemar ^d   Landgren, Ola ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Division of Cancer Epidemiology and Genetics   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLERGIC DISEASE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; CHRONIC PROSTATITIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GIANT CELL ARTERITIS; GINGIVITIS; GUILLAIN BARRE SYNDROME; HERPES ZOSTER; HUMAN; INFECTION; INFLAMMATORY DISEASE; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PERIODONTITIS; PNEUMONIA; PRIORITY JOURNAL; PYELONEPHRITIS; RHEUMATIC POLYMYALGIA; RISK FACTOR; SEPTICEMIA; SINUSITIS; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; WALDENSTROEM MACROGLOBULINEMIA; CASE CONTROL STUDY; CHRONIC DISEASE; CONFIDENCE INTERVAL; DISEASE PREDISPOSITION; HYPERSENSITIVITY; IMMUNOLOGY; MIDDLE AGED; PROSTATITIS; REGISTER; RISK; RISK ASSESSMENT; SEPSIS; STATISTICAL MODEL; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CHRONIC DISEASE; CONFIDENCE INTERVALS; CYTOMEGALOVIRUS INFECTIONS; DISEASE SUSCEPTIBILITY; FEMALE; GINGIVITIS; GUILLAIN-BARRE SYNDROME; HERPES ZOSTER; HUMANS; HYPERSENSITIVITY; INFECTION; INFLUENZA, HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PERIODONTITIS; PNEUMONIA; PROSTATITIS; PYELONEPHRITIS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEPSIS; SINUSITIS; SJOGREN'S SYNDROME; SWEDEN; WALDENSTROM MACROGLOBULINEMIA;

EID: 77951634157     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq043     Document Type: Article

References (31)

1. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003;30(2):110-115. (Pubitemid 36506291)
2. Björkholm M. Lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia. In: Canellos G, Lister A, Young B, eds. The Lymphomas. 2nd ed. Philadelphia, PA: W.B. Saunders; 2006:374-380.
3. Groves FD, Travis LB, Devesa SS, Ries LA, Fraumeni JF Jr. Waldenstrom's macroglobulinemia: incidence patterns in the United States, 1988-1994. Cancer. 1998;82(6):1078-1081. (Pubitemid 28136520)
4. Herrinton LJ, Weiss NS. Incidence of Waldenstrom's macroglobulinemia. Blood. 1993;82(10):3148-3150. (Pubitemid 23334943)
5. Dimopoulos MA, Panayiotidis P, Moulopoulos LA, Sfikakis P, Dalakas M. Waldenstrom's macroglobulinemia: clinical features, complications, and management. J Clin Oncol. 2000;18(1):214-226. (Pubitemid 30036355)
6. Fine JM, Lambin P, Massari M, Leroux P. Malignant evolution of asymptomatic monoclonal IgM after seven and fifteen years in two siblings of a patient with Waldenstrom's macroglobulinemia. Acta Med Scand. 1982;211(3):237-239. (Pubitemid 12192536)
7. McMaster ML, Goldin LR, Bai Y, et al. Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families. Am J Hum Genet. 2006;79(4):695-701. (Pubitemid 44452746)
8. Ogmundsdottir HM, Johannesson GM, Sveinsdottir S, et al. Familial macroglobulinaemia: hyperactive B-cells but normal natural killer function. Scand J Immunol. 1994;40(2):195-200. (Pubitemid 24251737)
9. McMaster ML, Csako G, Giambarresi TR, et al. Long-Term evaluation of three multiple-case Waldenstrom macroglobulinemia families. Clin Cancer Res. 2007;13(17):5063-5069. (Pubitemid 47502071)
10. Linet MS, Humphrey RL, Mehl ES, et al. A case-control and family study of Waldenstrom's macroglobulinemia. Leukemia. 1993;7(9):1363-1369. (Pubitemid 23291076)
11. Treon SP, Hunter ZR, Aggarwal A, et al. Characterization of familial Waldenstrom's macroglobulinemia. Ann Oncol. 2006;17(3):488-494.
12. Kristinsson SY, Bjorkholm M, Goldin LR, McMaster ML, Turesson I, Landgren O. Risk of lymphoproliferative disorders among first-degree rela-Tives of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia patients: a population-based study in Sweden. Blood. 2008;112(8):3052-3056.
13. Aoki H, Takishita M, Kosaka M, Saito S. Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenstrom's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL. Blood. 1995;85(7):1913-1919.
14. Wagner SD, Martinelli V, Luzzatto L. Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma. Blood. 1994;83(12):3647-3653.
15. Martin-Jimenez P, Garcia-Sanz R, Balanzategui A, et al. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenstrom's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance. Haematologica. 2007;92(5):635-642. (Pubitemid 350144265)
16. Smedby KE, Hjalgrim H, Askling J, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006;98(1):51-60. (Pubitemid 43057092)
17. Koshiol J, Gridley G, Engels EA, McMaster ML, Landgren O. Chronic immune stimulation and subsequent Waldenstrom macroglobulinemia. Arch Intern Med. 2008;168(17):1903-1909.
18. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007;297(18):2010-2017. (Pubitemid 46740353)
19. Nenasheva VV, Nikolaev AI, Martynenko AV, et al. Differential gene expression in HIV/SIV-Associated and spontaneous lymphomas. Int J Med Sci. 2005;2(4):122-128. (Pubitemid 41399702)
20. Nieters A, Beckmann L, Deeg E, Becker N. Gene polymorphisms in toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun. 2006;7(8):615-624. (Pubitemid 46242365)
21. Socialstyrelsen. Cancer Incidence in Sweden 2006. Stockholm, Sweden: National Board of Health and Welfare; 2007.
22. Turesson I, Linet MS, Bjorkholm M, et al. Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer. 2007;121(10):2260-2266. (Pubitemid 47585607)
23. Skarle A. Flergenerationsregistret. Stockholm, Sweden: Statistics Sweden, Population Statistics; 2001.
24. Landgren O, Engels EA, Pfeiffer RM, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst. 2006;98(18):1321-1330. (Pubitemid 44530727)
25. Ekstrom K, Hjalgrim H, Brandt L, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum. 2003;48(4):963-970. (Pubitemid 36418238)
26. Goldin L, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer. 2009;124(7):1497-1502.
27. Brown LM, Gridley G, Check D, Landgren O. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood. 2008;111(7):3388-3394.
28. Landgren O, Rapkin JS, Mellemkjaer L, Gridley G, Goldin LR, Engels EA. Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia. Haematologica. 2006;91(12):1697-1700. (Pubitemid 46032969)
29. Schollkopf C, Smedby KE, Hjalgrim H, et al. Hepatitis C infection and risk of malignant lymphoma. Int J Cancer. 2008;122(8):1885-1890. (Pubitemid 351413439)
30. Landgren O, Kyle RA. Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases. Br J Haematol. 2007;139(5):717-723. (Pubitemid 350115730)
31. Landgren O, Caporaso NE. New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2007;21(5):825-840. (Pubitemid 47496094)